Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H4O4.2C6H5Hg |
| Molecular Weight | 719.5 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Hg+]C1=CC=CC=C1.[Hg+]C2=CC=CC=C2.[O-]C(=O)C3=C(C=CC=C3)C([O-])=O
InChI
InChIKey=QFHSQCRSFKLKMT-UHFFFAOYSA-L
InChI=1S/C8H6O4.2C6H5.2Hg/c9-7(10)5-3-1-2-4-6(5)8(11)12;2*1-2-4-6-5-3-1;;/h1-4H,(H,9,10)(H,11,12);2*1-5H;;/q;;;2*+1/p-2
| Molecular Formula | C8H4O4 |
| Molecular Weight | 164.115 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H5Hg |
| Molecular Weight | 277.69 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Phenylmercuric borate is classified as antimicrobial preservative. It is bactericidal against many Gram-positive and Gram-negative species. Fungicidal activity has been demonstrated against Candida albicans and Aspergillus niger. Phenylmercuric borate (PHB) is very rapidly incorporated into the cells of Escherichia coli. On the membrane, an important part of PHB seems to be associated with the ribosomes and particularly to the ribosomal proteins. Phenylmercuric borate solution is indicated for the treatment of tonsillitis, otitis, vulvovaginitis, furuncles, anthrax and ulcers, pyoderma, impetus, gingivitis and stomatitis. The regular hand disinfection with a liquid soap containing phenylmercuric borate enhanced urinary excretion of mercury indicating an increase in total daily absorption of the toxic metal. The additional amounts of mercury absorbed through the use of mercury contained in skin disinfectants are potentially dangerous for human.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2363135 Sources: https://www.ncbi.nlm.nih.gov/pubmed/358679 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Merfen Approved Useindicated for the treatment of wounds, burns, ulcers, forúncles, anthrax, abscesses, pyodermitis, tinyes, vulvitis, vaginitis, vulvovaginitis. |
|||
| Primary | Merfen Approved Useindicated for the treatment of tonsillitis, otitis, vulvovaginitis, furuncles, anthrax and ulcers, pyoderma, impetus, gingivitis and stomatitis. |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13765256 |
Primary | Merfen Approved Useindicated for the treatment of wounds, burns, ulcers, forúncles, anthrax, abscesses, pyodermitis, tinyes, vulvitis, vaginitis, vulvovaginitis. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antimicrobial activity of seven metallic compounds against penicillinase producing and non-penicillinase producing strains of Neisseria gonorrhoeae. | 1986-06 |
|
| Studies on the mode of action of phenylmercuric borate on Escherichia coli. I. Structural localization and kinetics of incorporation. | 1978-06 |
|
| [Treatment of wounds with phenylmercuric borate (Merfen)]. | 1961-04-22 |
|
| [Contribution to the study of the inhibition of the action of phenylmercuric borate by the skin and the blood]. | 1960 |
|
| [Fatal allergic thrombopenia after influenza prophylaxis with phenylmercuric borate (merfen)]. | 1959-01-16 |
|
| [Use of phenylmercuric borate in parenteral solutions]. | 1958-12 |
|
| [Sterilization of suturing silk with 1:10 000 diluted phenylmercuric borate solution]. | 1956 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ub.edu/pharmakoteka/node/24992
Apply a thin layer of 0.04% ointment on the affected skin area
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3089906
Phenylmercuric borate inhibited 90% of all tested penicillinase (beta lactamase) producing strains of Neisseria gonorrhoeae (PPNG) and non-PPNGstrains at concentrations of 5 mg/l.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:51:45 GMT 2025
by
admin
on
Mon Mar 31 17:51:45 GMT 2025
|
| Record UNII |
FKL5QS2STU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
84-70-8
Created by
admin on Mon Mar 31 17:51:45 GMT 2025 , Edited by admin on Mon Mar 31 17:51:45 GMT 2025
|
PRIMARY | |||
|
4816
Created by
admin on Mon Mar 31 17:51:45 GMT 2025 , Edited by admin on Mon Mar 31 17:51:45 GMT 2025
|
PRIMARY | |||
|
16682927
Created by
admin on Mon Mar 31 17:51:45 GMT 2025 , Edited by admin on Mon Mar 31 17:51:45 GMT 2025
|
PRIMARY | |||
|
DTXSID101018974
Created by
admin on Mon Mar 31 17:51:45 GMT 2025 , Edited by admin on Mon Mar 31 17:51:45 GMT 2025
|
PRIMARY | |||
|
FKL5QS2STU
Created by
admin on Mon Mar 31 17:51:45 GMT 2025 , Edited by admin on Mon Mar 31 17:51:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |